Remote Patient Monitoring
for Conditions Affecting
the Respiratory System
PneumoWave aims to transform the way patients with respiratory conditions manage their health and live their lives.
Patient-Centred Management of Respiratory Illness
PneumoWave is an integrated platform of patient data capture and proprietary AI
analysis. Our solutions aim to facilitate a paradigm shift in respiratory care focusing
on intervention before disease or injury has advanced.
Our small, chest-worn biosensor continuously captures data and transmits it wirelessly for analysis
Proprietary algorithms aim to accurately detect a
range of respiratory adverse events in real-time
Processed data can be viewed in our cloud platform, allowing clinicians to remotely provide personalized treatment
Machine learning AI is applied to the data to identify digital biomarkers with predictive and preventive potential
Urgent Unmet Medical Need
The Opioid Epidemic Poses An Urgent Unmet Medical Need
From 1999–2019, in the USA alone nearly 500,000 people died from an overdose involving any opioid, including prescription and illicit opioids.
News
Keep updated on all PneumoWave’s news, events and latest press releases.
Clinical Trial Partners
Dr Gary Cooney appointed as Mental Health Lead
Dundee University start RESCU trial of PneumoWave’s wearable biosensor device aiming to cut opioid overdose deaths
PneumoWave & King’s College London Collaborate in Clinical Trial
PneumoWave and NHS Greater Glasgow & Clyde Announce Clinical Trial Aiming to Reduce Deaths from Respiratory Depression